Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bar

Showing results (231-240 of 237) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 237 results.
Journal of Dairy Science|March 27, 2010
Effects of clinical mastitis caused by gram-positive and gram-negative bacteria and other organisms on the probability of conception in New York State Holstein dairy cowsJ A Hertl, Y T Gröhn, J D G Leach, et al.
Annals of the New York Academy of Sciences|June 24, 2000
Gamma ray nuclear resonance absorption: an alternative method for in vivo body composition studiesD Vartsky, M B Goldberg, D Bar, et al.
Oncogenesis|September 4, 2019
NCAM1/FGF module serves as a putative pleuropulmonary blastoma therapeutic targetRachel Shukrun, Hana Golan, Revital Caspi, et al.
Frontiers in Bioengineering and Biotechnology|October 10, 2025
A novel Frizzled 7 antibody disrupts the Wnt pathway and inhibits Wilms tumor growthEinav Vax, Revital Caspi, Rachel Shukrun, et al.
Stem Cell Reports|August 21, 2018
In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an ExampleHana Golan, Rachel Shukrun, Revital Caspi, et al.
EMBO Molecular Medicine|December 3, 2017
Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic targetOren Pleniceanu, Racheli Shukrun, Dorit Omer, et al.
EMBO Molecular Medicine|March 10, 2017
Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic targetOren Pleniceanu, Racheli Shukrun, Dorit Omer, et al.
Pageof 24

Showing results (231-240 of 237) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 237 results.
Journal of Dairy Science|March 27, 2010
Effects of clinical mastitis caused by gram-positive and gram-negative bacteria and other organisms on the probability of conception in New York State Holstein dairy cowsJ A Hertl, Y T Gröhn, J D G Leach, et al.
Annals of the New York Academy of Sciences|June 24, 2000
Gamma ray nuclear resonance absorption: an alternative method for in vivo body composition studiesD Vartsky, M B Goldberg, D Bar, et al.
Oncogenesis|September 4, 2019
NCAM1/FGF module serves as a putative pleuropulmonary blastoma therapeutic targetRachel Shukrun, Hana Golan, Revital Caspi, et al.
Frontiers in Bioengineering and Biotechnology|October 10, 2025
A novel Frizzled 7 antibody disrupts the Wnt pathway and inhibits Wilms tumor growthEinav Vax, Revital Caspi, Rachel Shukrun, et al.
Stem Cell Reports|August 21, 2018
In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an ExampleHana Golan, Rachel Shukrun, Revital Caspi, et al.
EMBO Molecular Medicine|December 3, 2017
Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic targetOren Pleniceanu, Racheli Shukrun, Dorit Omer, et al.
EMBO Molecular Medicine|March 10, 2017
Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic targetOren Pleniceanu, Racheli Shukrun, Dorit Omer, et al.
Pageof 24